The objective of the study was to investigate the ethyl acetate extract of Morinda morindoides (Baker) Milne-Redh (Rubiaceae) (MM-EA) properties against experimental diarrheoa induced by castor oil in albino Wistar rats. Methods: The ethyl acetate extract of Morinda morindoides (250, 500, and 1000 mg/kg body weight) was administered orally to three groups of rats (five animals per group) in order to evaluate the activity of the extract against castor oil-induced diarrhea model in rat. Two other groups received normal saline (5mg/kg) and loperamide (5mg/kg) as positive control. The effect of the extract on intestinal transit and castor oil-induced intestinal fluid accumulation (enteropooling) was assessed. Results: At oral doses of 250, 500, and 1000 mg/kg body weight, the plant extract showed pronounced and dose-dependent antidiarrheal activity. The protective role of the extract at 1000 mg/kg was comparable to that of the reference drug, loperamide (5mg/kg). The extract (1000 mg/kg) produced a decrease in intestinal transit comparable to atropine (5mg/kg), and significantly (p<0.01) inhibited castor oil-induced enteropooling. No mortality and visible signs of general weakness were observed in the rats following the extract administration of up to a dose of 6000 mg/kg. Conclusion: The results showed that the extract of M. morindoides has a significant antidiarrheal activity which supports its use in traditional herbal medicine practice.
INTRODUCTION
Diarrheal diseases are a major problem in Third World countries and are responsible for the death of millions of people each year 1 .
Diarrheoa is an alteration in normal bowel movement and is characterized by an increase in the water content, volume, or frequency of stools 2 . Plants have long been a very important source of new drugs. Many plant species have been screened for substances with therapeutic activity. Medicinal plants are a promising source of antidiarrheal drugs 3 . For this reason, international organizations including the World Health Organization (WHO) have encouraged studies pertaining to the treatment and prevention of diarrheal diseases using traditional medical practices 4, 5, 6 . Morinda morindoides (Baker) Milne-Redh (Rubiaceae) is found in the borders of tropical forests. In the Democratic Republic of Congo, M. morindoides has long been used in villages and towns in the treatment of some parasitic diseases, and the leaf extracts of the plant have been shown to possess antiprotozoal activity particularly against Entamoeba histolytica and rheumatic pain 7, 8 . The decoction of the leaves is used for the treatment of malaria, intestinal worms, and amoebiasis 9, 10 . Recently Zirihi et al 11 have shown that the ethanol extract of M. morindoides exhibited good in vitro antimalarial activity against chloroquineresistant FcB1/Colombia strain of Plasmodium falciparum.
Ten flavonoids which were identified as quercetin, quercetin-7, [12] [13] [14] have been isolated from the butanol and ethyl acetate fractions of the plant leaves. In addition, a total of eight iridoid glycosides, among which are gaertneroside and gaertneric acid, methoxygaertneroside and epoxygaertneroside, were also isolated from the same fractions by Cimanga et al 8 .
M. morindoides is well known in the traditional medical practice of the west central part of Ivory Coast. It is commonly called Zêlékelé in the local language of 'Bété' and is used as an antifungal agent. The leaves of the plant are used in traditional medicine to treat diarrheoa. The present work was undertaken to investigate the potential in vivo antidiarrheal effect of the ethyl acetate extract of M. morindoides in various experimental models of diarrhoea in rats.
MATERIALS AND METHODS

Plant material
The 
Preparation of ethyl acetate extract
The leaves of M. morindoides were cleaned of extraneous matter, air-dried at room temperature for 7 days and ground into a fine powder. The powder was mixed with distilled water (80 g of powder in 2 L of distilled water) for 24 h with constant stirring at 80°C. The extract was filtered twice through cotton wool, then through Whatman filter paper (No. 1). The filtrate was evaporated to dryness using a rotary evaporator (Buchi). Twenty five grams (25 g) of the dry aqueous extract was dissolved in 500 ml of ethanol and water (consisting of 350 ml of ethanol 96% and 150 ml of distilled water) and after thorough mixing, the supernatant was evaporated using a rotary evaporator. Following the method of Guede-Guina et al 15 , 25 g of the dried extract was dispersed in 500 ml of a solution (made up of 250 ml of ethyl acetate and 250 ml of distilled water), and mixed for 24 h with constant stirring. From the two phases formed, the supernatant was evaporated using a rotary evaporator, and the resulting dry powder was taken as the ethyl acetate extract.
Animal
Albino Wistar rats (weighing 150 -200 g) of both sexes, were housed in standard metal cages. They were provided with food and water ad libitum, and allowed a one-week acclimatization period prior to the study. The equipment, handling and sacrificing of the animals were in accordance with the European Council legislation 87/609/EEC for the protection of experimental animals 16 .
Drug and chemicals
Atropine sulphate and loperamide (Sigma Chemical Co, St Louis, Mo, USA), castor oil (Qualikems Fine Chemicals Pvt. Ltd, New Delhi, India), normal saline (NaCl 0.9%) and charcoal meal (10% activated charcoal in 100 ml of 5% aqueous gum acacia) were used.
Preliminary acute toxicity test
The extract of M. morindoides was administered orally in doses of 125, 250, 500, 1000, 2000, 4000 and 6000 mg/kg body weight to animal groups (one dose per group). Simultaneously, the control animals received normal saline (5ml/kg). The general signs and symptoms of toxicity, intake of food and water and mortality were recorded for a period of 48 h and then for a period of 14 days.
Castor oil-induced diarrhea in rats
Twenty five (25) rats were fasted for 18 h and divided into five groups of five animals each. The plant extract (250, 500, and 1000 mg/kg body weight) were administered orally to groups 1, 2 and 3, respectively. The fourth group received normal saline (5 ml/kg body weight) and served as control, while the fifth group received the standard drug, loperamide (5 mg/kg body weight). One hour later, all the animals received 2 ml/rat of castor oil orally by gavage. The animals were kept in separate metabolic cages with a transparent plastic container beneath the cage to collect faeces 17 . The severity of diarrheoa was assessed each hour for 6 h. The total number of faeces (both diarrheal and non-diarrheal) expelled were compared with the control group. The total score of diarrheal faeces for the control group was considered as 100%. The results were expressed as a percentage of inhibition of diarrheoa.
Gastrointestinal motility test
The rats were divided into five groups of five animals each and fasted for 18 h but water was freely provided. The first group (control group) received orally normal saline (5 ml/kg body weight), while the second, third and fourth groups were given orally the plant extract in doses of 250, 500, and 1000 mg/kg body weight, respectively. The fifth group received orally the standard drug, atropine sulphate (5 mg/kg body weight). Thirty (30) min later, each animal was given 1 ml/rat of charcoal meal (10% activated charcoal in 5% gum acacia) via the oral route. All animals were sacrificed 30 min thereafter, and the distance covered by the charcoal meal in the intestine, from the pylorus to the caecum was measured and expressed as percentage of distance moved 18 .
Castor oil-induced enteropooling
Intraluminal fluid accumulation was determined by the method of Robert et al 19 .
Rats were divided into five groups of five animals each, one hour before oral administration of castor oil (2 ml/rat). Group 1 received normal saline orally (5 ml/kg body weight), and served as the control. Group 2 animals received loperamide (5mg/kg, oral) while groups 3, 4, and 5 received, by oral intubation, the extract of M. morindoides at doses of 250, 500 and 1000 mg/kg body weight, respectively. Two hours later, the rats were sacrificed and the small intestine from the pylorus to the caecum was isolated. The intestinal contents were collected by milking into a graduated tube and their volume measured.
Statistical analysis
Data were analyzed by one-way ANOVA followed by Dennett's t-test using Instat ® (Graph Pad software, U.S.A). At 95% confidence interval p<0.05 was considered statistically significant.
RESULTS
Preliminary acute toxicity test
It was observed that oral administration of the extract of M. morindoides to the rat up to 6000 mg/kg neither showed mortality nor any apparent signs of weakness in the animals.
Effect of M. morindoides extract on castor oil-induced diarrheoa
In the castor oil-induced diarrheoa experiment, the extract of M. morindoides produced a marked antidiarrheal effect in the rats, as shown in Table 1 . At doses of 250, 500, and 1000 mg/kg, the extract significantly decreased (p < 0.01) the total number of wet faeces produced upon administration of castor oil (12.20 ± 1.06 at 250 mg/kg, 7.00 ± 0.94 at 500 mg/kg and 6.20 ± 0.58 at 1000 mg/kg) compared to the control group (18.6 ± 0.74). The effect of the highest dose of the extract was similar to that of the standard drug, loperamide (5 mg/kg).
Effect of M. morindoides extract on intestinal transit of charcoal meal
The extract of M. morindoides decreased propulsion of charcoal meal in the rat gastrointestinal tract at oral doses of 250 -1000 mg/kg, compared with the control group that receiving normal saline (5 mg/kg). A similar reduction in the gastrointestinal transit of charcoal meal in rat was achieved with atropine sulphate (5 mg/kg). The results are shown in Table 2 .
Effect of extract of M. morindoides on castor oil-induced enteropooling
Morinda morindoides extract significantly (P < 0.01) inhibited castor oil-induced enteropooling in rats at oral doses of 500 and 1000 mg/kg ( Table 3 ). The intestinal fluid in control animals was 3.44 ± 0.36 ml. The inhibition of intestinal accumulation was 24.41% (P < 0.01), 52.32% (P < 0.01) and 61.04 % (P < 0.01) at doses of 250, 500, and 1000 mg/kg of the extract, respectively. The standard drug, loperamide (5 mg/kg), also significantly inhibited (P < 0.01) intestinal fluid accumulation (59.30%).
DISCUSSION
In the traditional medicine system, Morinda morindoides is used in the management of diarrheoa by traditional medicine practitioners in Ivory Coast. The present study sought to assess the antidiarrheal activity of the plant. Our results showed that the extract inhibited significantly (p < 0.01) castor oil-induced diarrheoa in rats. Several mechanisms had been previously proposed to explain the diarrheal effect of castor oil. These include inhibition of intestinal Na + K + ATPase activity, thus reducing normal fluid absorption 20 , activation of adenylate cyclase or mucosal cAMP-mediated active secretion 21 , stimulation of prostaglandin formation 22 , and platelet activating factor 23 . Most recently nitric oxide has been claimed to contribute to the diarrheal effect of castor oil 24 . However, it is well documented that castor oil produces diarrhoea due to its most active component ricinoleic acid through a hypersecretory response 25, 26 . Therefore it can be assumed that the antidiarrheal action of the extract was mediated by an antisecretory mechanism. This was also evident from the inhibition of castor oil-induced fluid accumulation by the extract. The results were comparable to those of the standard drug, loperamide. Values are expressed as mean ± S.E.M (n = 5) *P <0.05, **p < 0.0 1, when compared to the control Values are expressed as mean ± S.E.M (n = 5) **p < 0.0 1, when compared to the control able to inhibit the intestinal secretory response induced by prostaglandins E 2 31 . In addition, flavonoids present antioxidant properties 32 which are presumed to be responsible for the inhibitory effects exerted upon several enzymes including those involved in the arachidonic acid metabolism 33 . These constituents may be responsible for the antidiarrheal activity of the ethyl acetate extract of M. morindoides.
